OCUL 10-Q: SEC filing
Ocular Therapeutix
Filed with the SEC on · accession 0001104659-26-124155
OCUL filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +3.9% by the first close after the filing.
Summary of the filing
Ocular Therapeutix filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.
Key details
How OCUL stock reacted
Close before
$6.59
Nov 6, 2026
First close after
+3.87%
$6.85
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for OCUL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OCUL?
Click hereFrequently asked questions
What did OCUL file with the SEC on Nov 9, 2026?
OCUL filed a 10-Q (SEC filing). Ocular Therapeutix filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did OCUL stock react to this filing?
OCUL closed at $6.59 before the filing and $6.85 on Nov 9, 2026 (+3.87%).
Other OCUL SEC filings
Get alerts when OCUL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days